METHOD OF COMBINED TREATMENT OF NON-SMALL CELL LUNG CANCER OF II AND III STAGE

摘要

FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention relates to medicine, namely to oncology, and deals with method of combined treatment of non-small cell lung cancer of II and III stage. Method includes 2 courses of neoadjuvant chemotherapy with application of carboplatin and further radical surgery. Neoadjuvant therapy is carried out by intravenous introduction of vinorelbine in dose 25 mg/ m2 on 1 and 8 days of cycle, on the second day, 20 hours after introduction of vinorelbine carboplatin is introduced intravenously by drop infusion in dose by AUG 6, interval between courses of chemotherapy constitutes 20 days. After that in post-operative period on 14 day additionally carried out is adjuvant chemotherapy in the same regimen, with number of course being 3-4. ^ EFFECT: invention ensures increased efficiency of treatment of non-small cell lung cancer of II and III stage due to reduction of complications and increase of patients' survival. ^ 2 ex